Welcome to LookChem.com Sign In|Join Free
  • or
(E)-4-Bromostyryl-4-nitrobenzylsulfone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

334969-04-9

Post Buying Request

334969-04-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

334969-04-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 334969-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,4,9,6 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 334969-04:
(8*3)+(7*3)+(6*4)+(5*9)+(4*6)+(3*9)+(2*0)+(1*4)=169
169 % 10 = 9
So 334969-04-9 is a valid CAS Registry Number.

334969-04-9Downstream Products

334969-04-9Relevant academic research and scientific papers

Synthesis and biological evaluation of [4-(2-phenylethenesulfonylmethyl) phenyl]-quinazolin-4-yl-amines as orally active anti-cancer agents

Sharma, Vedula M.,Seshu, K. V. Adi,Sekhar, V. Chandra,Madan, Sachin,Vishnu,Babu, P. Aravind,Krishna, C. Vamsee,Sreenu,Krishna, V. Ravi,Venkateswarlu,Rajagopal, Sriram,Ajaykumar,Kumar, T. Sravan

, p. 67 - 71 (2007/10/03)

A new series of [4-(2-phenylethenesulfonylmethyl)phenyl]quinazolin-4-yl- amines was prepared and tested for its in vitro cytotoxic activity against a panel of 12 human cancer cell lines. Compounds 9, 15, 24 and 31 showed good in vitro activity and were further tested for their in vivo efficacy in the HT-29 human colon adeno carcinoma xenograft model. Compound 9 exhibited promising activity in this model. Dose-response studies for this compound against HT-29 human colon adeno carcinoma xenografts at 100, 200 and 400 mg/kg doses were performed.

(E)-4-carboxystyrl-4-chlorobenzyl sulfone and pharmaceutical compositions thereof

-

, (2008/06/13)

Pre-treatment with α,β unsaturated aryl sulfones protects normal cells from the cytotoxic side effects of two classes of anticancer chemotherapeutics. Administration of a cytoprotective sulfone compound to a patient prior to anticancer chemotherapy with a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 334969-04-9